Q9D-10062-84432
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 330 / FL
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
- 2021-02-28
-
2021-03-02
Survey response — days 1–6 daily, dose 1MedDRA: Musculoskeletal stiffness — Feeling: GoodFree text: stiffness in neck & shoulders (very mild)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-08
-
2021-03-19
Dose 2 — Pfizer-BioNTech
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-03-21
- 2021-03-26
-
2021-06-20
Survey response — 3 months, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: worsened period symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): stiffness in neck & shoulders (very mild)
Release 9 — 3 months, dose 2
Symptoms: worsened period symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release